Search

everythinglearnresearchcommunity

for

Search:↓

The meeting discussed medical findings, including benefits of certain treatments for cancer and heart conditions, and highlighted issues like poor adherence to preventive measures and skill gaps among interns.

Eosinophilia-myalgia syndrome, linked to contaminated L-tryptophan supplements, caused severe symptoms and some deaths, with long-term effects in survivors.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

Hair follicle stem cells are key for hair and skin regeneration, can be reprogrammed, and have potential therapeutic uses, but also carry a risk of cancer.

Cancer prevention has progressed with successful drugs and vaccines, but challenges remain in understanding genetic changes and improving strategies.

Vijaya successfully fought stage 2A breast cancer with surgery, chemotherapy, radiotherapy, and hormone therapy, while advocating for support groups.

The link between anabolic agents and colorectal cancer risk is unclear.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

New cooling caps can help prevent hair loss from chemotherapy in a cost-effective and eco-friendly way.

Many COVID-19 survivors, especially women, experience hair loss and skin color changes, needing specific post-recovery care.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

Nanocarriers can improve skin treatments after cancer therapy by enhancing antioxidant delivery and effectiveness.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

SCUBE3 is a potential target for cancer and alopecia treatment but is challenging to target due to its varied roles.

Insurers opposed ASCO's recommendation for a single cancer care pathway program.

Better supportive care is needed to manage chemotherapy side effects.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

Dr. Mario Lacouture recommends preventive and specific treatments for skin side effects caused by EGFR inhibitors to improve patients' quality of life.

Proton minibeam radiotherapy shows promise for sparing healthy tissue in cancer treatment but needs further research and technological development.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

Understanding metabolic changes in dormant cells can help treat cancer.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Primary healthcare clinics are key in managing chemotherapy side effects using various medications and treatments.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

No treatment fully prevents hair loss from chemotherapy yet.

Obesity increases the risk of skin infections, inflammatory conditions, and melanoma, but not basal cell carcinoma.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.